Current Issue


Report and study highlight risk of heart failure in patients with diabetes

The American Diabetes Association made recommendations on diagnosing and treating heart failure in patients with diabetes, and a study found increased risk of progression to clinical heart failure in those with an HbA1c level of 7% or above.

SGLT-2 inhibitors associated with reduced heart failure events versus metformin

A retrospective study of patients who took sodium-glucose cotransporter-2 (SGLT-2) inhibitors or metformin as first-line therapy for type 2 diabetes found similar risk for myocardial infarction and stroke with the two drug classes but a difference in hospitalizations for heart failure.

Whole, plant-based diet most effective for type 2 diabetes remission, ACLM says

Diet as a primary intervention can achieve remission for many with type 2 diabetes and should focus on plant-based foods with minimal consumption of meat and other animal products, according to a statement from the American College of Lifestyle Medicine (ACLM).

MKSAP quiz: Medication for heart failure and diabetes

This month's quiz asks readers to evaluate a 57-year-old woman with a history of ischemic cardiomyopathy with an ejection fraction of 38%, type 2 diabetes, and diabetic kidney disease during a routine follow-up visit.

Spotlight on tirzepatide

The first glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist was approved by the FDA and analyzed by a number of recent studies.

No additional benefit seen for self-monitored blood glucose with community health worker support

In a small trial, patients with insulin-treated diabetes were randomly assigned to usual care, a lottery incentive for daily self-monitored blood glucose, or the lottery plus support from a community health worker if needed.